| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |